141 related articles for article (PubMed ID: 9155044)
1. Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
Barbieri F; Cagnoli M; Ragni N; Pedullà F; Foglia G; Alama A
Br J Cancer; 1997; 75(9):1263-8. PubMed ID: 9155044
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle-dependent expression of cyclin D1 and a 45 kD protein in human A549 lung carcinoma cells.
Wu F; Bui KC; Buckley S; Warburton D
Am J Respir Cell Mol Biol; 1994 Apr; 10(4):437-47. PubMed ID: 8136159
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cyclin D1 in epithelial ovarian cancers.
Worsley SD; Ponder BA; Davies BR
Gynecol Oncol; 1997 Feb; 64(2):189-95. PubMed ID: 9038263
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of cyclin D1 messenger RNA expression in head and neck squamous cell carcinomas.
Monden N; Nishizaki K; Fukushima K; Masuda Y; Tsukuda K; Shimizu K
Jpn J Cancer Res; 1997 Jul; 88(7):660-8. PubMed ID: 9310139
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas.
Masciullo V; Scambia G; Marone M; Giannitelli C; Ferrandina G; Bellacosa A; Benedetti Panici P; Mancuso S
Int J Cancer; 1997 Aug; 74(4):390-5. PubMed ID: 9291427
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
Naitoh H; Shibata J; Kawaguchi A; Kodama M; Hattori T
Am J Pathol; 1995 May; 146(5):1161-9. PubMed ID: 7747810
[TBL] [Abstract][Full Text] [Related]
8. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
9. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.
Furlanetto RW; Harwell SE; Frick KK
Mol Endocrinol; 1994 Apr; 8(4):510-7. PubMed ID: 8052269
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
Hung WC; Huang JS; Chuang LY
Biochem Biophys Res Commun; 1996 Mar; 220(3):719-23. PubMed ID: 8607831
[TBL] [Abstract][Full Text] [Related]
12. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
13. Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.
Barbieri F; Cagnoli M; Ragni N; Foglia G; Bruzzo C; Pedullà F; Alama A
Clin Cancer Res; 1999 Jul; 5(7):1837-42. PubMed ID: 10430089
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of nucleostemin expression and its correlation with cyclin D1 expression in malignant ovarian tumors.
Lin S; Yu HS
Int J Gynecol Cancer; 2011 Oct; 21(7):1166-71. PubMed ID: 21892090
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.
Wu GQ; Xie D; Yang GF; Liao YJ; Mai SJ; Deng HX; Sze J; Guan XY; Zeng YX; Lin MC; Kung HF
Int J Cancer; 2009 Dec; 125(11):2631-42. PubMed ID: 19672860
[TBL] [Abstract][Full Text] [Related]
17. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB
Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595
[TBL] [Abstract][Full Text] [Related]
19. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
Nikaido T; Li SF; Shiozawa T; Fujii S
Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
[TBL] [Abstract][Full Text] [Related]
20. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.
Liu JJ; Chao JR; Jiang MC; Ng SY; Yen JJ; Yang-Yen HF
Mol Cell Biol; 1995 Jul; 15(7):3654-63. PubMed ID: 7791772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
